Trademark: 77600189
Status Date
Thursday, March 7, 2019
Registration Number
3690806
Registration Date
Tuesday, September 29, 2009
Filing Date
Friday, October 24, 2008
35 Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
40 Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals
42 Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics
45 Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Mar 7, 2019
Notice Of Acceptance Of Sec. 8 & 9 - E-Mailed
Mar 7, 2019
Registered And Renewed (First Renewal - 10 Yrs)
Mar 7, 2019
Registered - Sec. 8 (10-Yr) Accepted/Sec. 9 Granted
Mar 7, 2019
Case Assigned To Post Registration Paralegal
Feb 3, 2019
Teas Section 8 & 9 Received
Sep 29, 2018
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Jun 20, 2016
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 20, 2016
Teas Change Of Owner Address Received
Sep 25, 2015
Notice Of Acceptance Of Sec. 8 - E-Mailed
Sep 25, 2015
Registered - Sec. 8 (6-Yr) Accepted
Sep 24, 2015
Case Assigned To Post Registration Paralegal
Sep 14, 2015
Teas Section 8 Received
Apr 7, 2010
Automatic Update Of Assignment Of Ownership
Sep 29, 2009
Registered-Supplemental Register
Aug 25, 2009
Law Office Publication Review Completed
Aug 25, 2009
Assigned To Lie
Aug 20, 2009
Approved For Registration Supplemental Register
Aug 20, 2009
Use Amendment Accepted
Aug 7, 2009
Teas/Email Correspondence Entered
Aug 6, 2009
Correspondence Received In Law Office
Aug 6, 2009
Teas Response To Office Action Received
Aug 4, 2009
Amendment To Use Processing Complete
Aug 4, 2009
Use Amendment Filed
Aug 3, 2009
Teas Amendment Of Use Received
Jul 29, 2009
Teas/Email Correspondence Entered
Jul 29, 2009
Correspondence Received In Law Office
Jul 29, 2009
Teas Response To Office Action Received
Feb 3, 2009
Notification Of Non-Final Action E-Mailed
Feb 3, 2009
Non-Final Action E-Mailed
Feb 3, 2009
Non-Final Action Written
Jan 27, 2009
Assigned To Examiner
Oct 29, 2008
Notice Of Pseudo Mark Mailed
Oct 28, 2008
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
